March 20, 2009
Systat Software, Inc., (SSI) announced today that it has signed an agreement with Rescentris, Inc. of Columbus, OH, to globally offer their joint product, SigmaCERF ™ - an Electronic Lab Notebook (ELN) and knowledge management platform for life science research organizations. San Jose, CA, USA (PRWEB) March 20, 2009 -- Systat Software, Inc., (SSI) announced [...]
CyBio and Axxam Develop a New System for High Throughput Screening
March 20, 2009
Expanding capabilities in robotic HTS Jena, Germany and Milan, Italy, March 20th 2009 - CyBio AG and Axxam SpA announce that they have developed, installed and fully validated a new state-of-the-art screening station to be used by Axxam in running hit discovery campaigns with automated luminescence and fluorescence screening systems. CyBio AG is a worldwide [...]
Pressure BioSciences, Inc. Provides Corporate Update
March 20, 2009
SOUTH EASTON, Mass., March 20 -- Pressure BioSciences, Inc. (Nasdaq: PBIO - News; "PBI" and the "Company") today provided an update on various corporate activities, including (1) the receipt of a Phase I Small Business Innovation Research ("SBIR") Grant from the National Institutes of Health ("NIH"), (2) a presentation by Dr. Alexander Ivanov of the [...]
New technique used to profile anthrax genome
March 20, 2009
Scientists at the Georgia Institute of Technology have used a new approach, known as RNA-Seq, to profile the gene expression of the bacterium that causes anthrax, Bacillus anthracis. Their study, published March 20, 2009, online by the Journal of Bacteriology, marks the first time any bacterial transcriptomethe complete collection of mRNAs produced by a bacterium [...]
CalBioreagents announces the release of 6 NEW Monoclonal Antibodies for MRSA.
March 20, 2009
MRSA are strains of Staphylococcus aureus that have developed resistance to beta lactam antibiotics. Resistance to these antibiotics is mediated by the MRSA MecA gene and the resulting mutant penicillin binding protein 2a (PBP2a). A series of monoclonal antibodies specific for the MRSA PBP2a protein have been developed by CalBioreagents' partner company DINONA, Inc., (Korea). [...]
March 19, 2009
SINGAPORE—March 19, 2009: —GE Water, a business unit of GE Energy, and the National University of Singapore (NUS) announced that they have signed an agreement to establish the NUS-GE Singapore Water Technology Center on the campus of NUS. Together, GE and NUS are investing US$100 million (SGD$150 million) in the NUS-GE Singapore Water Technology Center. [...]
Screening Pressure Reactor accelerates catalyst and process optimisation…
March 19, 2009
Symyx Technologies Europe has announced the availability of the Symyx Screening Pressure Reactor (SPR), a high-throughput research system that enables up to a 100-fold increase in the speed of screening and optimising catalysts and catalytic processes. The Symyx SPR is available for refining, petrochemical and fine chemical applications. It encompasses Symyx's chemistry, engineering and software [...]
Easy-to-use Protein Precipitation Cartridge
March 19, 2009
KINGSTON, England, March 19, 2009--The new 1ml Protein Precipitation Cartridge from Porvair Sciences Ltd. uniquely combines the proven operational benefits of proprietary p3 technology with the low cost and convenience of a cartridge-based separation methodology. Incorporating a novel treated dual matrix frit the new p3 cartridge eliminates the wetting-out and leaking of sample associated with [...]
Phenomenex, A Torrance Technology Company, Wears Red for Charity
March 19, 2009
TORRANCE, Calif.--Phenomenex Inc., a global leader in the manufacture of separation science consumables, had a blast last Friday, all in the name of charity. Hundreds of Phenomenex employees around the world showed up to work dressed in the most ridiculous attire they could gather with the only rule being: it had to be red and [...]
March 19, 2009
WOONSOCKET, R.I., March 19 --MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today that it has entered into a cooperative research and development agreement with Maxim Biotech, Inc. to develop products for the study of liver stem cells and liver cancer. Tumor tissues are composed of a mixture of cells with some tumor cells exhibiting [...]
